175 related articles for article (PubMed ID: 29268772)
1. A functional role of LEFTY during progesterone therapy for endometrial carcinoma.
Fei W; Kijima D; Hashimoto M; Hashimura M; Oguri Y; Kajita S; Matsumoto T; Yokoi A; Saegusa M
Cell Commun Signal; 2017 Dec; 15(1):56. PubMed ID: 29268772
[TBL] [Abstract][Full Text] [Related]
2. Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma.
Matsumoto T; Chino H; Akiya M; Hashimura M; Yokoi A; Tochimoto M; Nakagawa M; Jiang Z; Saegusa M
Mol Carcinog; 2020 Dec; 59(12):1409-1419. PubMed ID: 33111989
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
[TBL] [Abstract][Full Text] [Related]
5. TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas.
Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Akiya M; Saegusa M
Mol Carcinog; 2018 Aug; 57(8):957-967. PubMed ID: 29603383
[TBL] [Abstract][Full Text] [Related]
6. Expression of nodal signalling components in cycling human endometrium and in endometrial cancer.
Papageorgiou I; Nicholls PK; Wang F; Lackmann M; Makanji Y; Salamonsen LA; Robertson DM; Harrison CA
Reprod Biol Endocrinol; 2009 Oct; 7():122. PubMed ID: 19874624
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
8. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
[TBL] [Abstract][Full Text] [Related]
9. Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.
Miura R; Yokoi A; Matsumoto T; Oguri Y; Hashimura M; Tochimoto M; Kajita S; Saegusa M
BMC Cancer; 2019 Apr; 19(1):308. PubMed ID: 30943930
[TBL] [Abstract][Full Text] [Related]
10. Expression of uteroglobin in normal and carcinogenic endometrium and influence of hormone replacement therapy.
Tanaka R; Saito T; Shijubo N; Takehara M; Yamada G; Kawabata I; Itoh Y; Kudo R
Int J Cancer; 2004 Mar; 109(1):43-8. PubMed ID: 14735466
[TBL] [Abstract][Full Text] [Related]
11. Expression of endometrial glycogen synthase kinase-3beta protein throughout the menstrual cycle and its regulation by progesterone.
Salameh W; Helliwell JP; Han G; McPhaul L; Khorram O
Mol Hum Reprod; 2006 Sep; 12(9):543-9. PubMed ID: 16882987
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
13. Role of progesterone in endometrial cancer.
Kim JJ; Chapman-Davis E
Semin Reprod Med; 2010 Jan; 28(1):81-90. PubMed ID: 20104432
[TBL] [Abstract][Full Text] [Related]
14. Lefty A protein inhibits TGF-β1-mediated apoptosis in human renal tubular epithelial cells.
Zheng RP; Bai T; Zhou XG; Xu CG; Wang W; Xu MW; Zhang J
Mol Med Rep; 2013 Aug; 8(2):621-5. PubMed ID: 23807264
[TBL] [Abstract][Full Text] [Related]
15. Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways.
Sun G; Shi L; Li M; Jiang N; Fu L; Guo J
J Neurol Sci; 2014 Dec; 347(1-2):137-42. PubMed ID: 25304053
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
17. Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells.
Kim MR; Park DW; Lee JH; Choi DS; Hwang KJ; Ryu HS; Min CK
Mol Hum Reprod; 2005 Nov; 11(11):801-8. PubMed ID: 16403803
[TBL] [Abstract][Full Text] [Related]
18. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway.
Saegusa M; Hashimura M; Suzuki E; Yoshida T; Kuwata T
Am J Pathol; 2012 Aug; 181(2):684-92. PubMed ID: 22698986
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
